This article is 4 years old
Shot in the dark: Early Covid-19 vaccine efficacy explained
This week has seen a flurry of good news from Covid-19 vaccine developers, with Pfizer Inc and BioNTech SE trumpeting early data indicating their mRNA candidate is more than 90 percent effective.
A Russian project came out a day later, touting 92 percent efficacy for the Sputnik V candidate, named after the Soviet-era satellite, based on a smaller data set...
Verifying user
RM12.50 / month
- Unlimited access to award-winning journalism
- Comment and share your opinions on all our articles
- Gift interesting stories to your friends
- Tax deductable